Zobrazeno 1 - 10
of 91
pro vyhledávání: '"I, Adamakis"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Salvia sclarea L. is a Cd2+ tolerant medicinal herb with antifungal and antimicrobial properties cultivated for its pharmacological properties. However, accumulation of high Cd2+ content in its tissues increases the adverse health effects of Cd2+ in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::cfbc88cb1b1b6cb62a40d7cbb43e2e76
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2980563
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2980563
The herbal plant Salvia sclarea L. (clary sage) is classified to cadmium (Cd) accumulators and considered as a potential plant for phytoremediation of heavy metal polluted soil. However, the effect of Cd only treatment on the function of the photosyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::99baa1cac34a33726eec6dc8ab0f24b6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057495
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057495
In recent years, due to the development of industrial and agricultural production, heavy metal contamination has attracted increasing attention. Aromatic and medicinal plant Salvia sclarea L. (clary sage) is classified to zinc (Zn) accumulators and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::c6595d8dba2808dcbf0917f04dbc3a72
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057491
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3057491
Autor:
I. Adamakis, C. Pournaras, I. Katafigiotis, G. Kousournas, E. Fragkiadis, I. Leotsakos, C. Alamanis, D. Mitropoulos, C. Constantinides
Publikováno v:
Case Reports in Medicine, Vol 2013 (2013)
Our goal is to describe our experience in the difficulties encountered during radical cystectomy for muscle invasive bladder cancer in patients with contemporary pelvic kidney. Two patients with muscle invasive bladder cancer and contemporary pelvic
Externí odkaz:
https://doaj.org/article/9152efa3046b474980f57b3727bc07e1
We identified the incidence and risk factors of venous thromboembolism in 335 chemotherapy-treated patients with urothelial cancer. The Khorana risk score did not accurately predict risk for thromboembolic events; on the contrary, history of vascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::90a3faca8ccf7e1415d39e0143c9ff5f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120930
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120930
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
In this study, for a first time (according to our knowledge), we couple the methodologies of chlorophyll fluorescence imaging analysis (CF-IA) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS), in order to investigate the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1d2463a2c3b7f55b26bd06743393bcea
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3059186
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3059186
Purpose: To identify prognostic molecular profiles in patients with mRCC treated with sunitinib, we performed immunohistochemical analysis for VEGF and PI3K/Akt/mTOR pathway components. Methods: The immunohistochemical expression of VEGF, p85α, p110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7bfa7b3498613c8d75912aefafa2383a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126377
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126377
Autor:
I, Adamakis, I, Katafigiotis, S I, Tyritzis, V, Mygdalis, S, Sfoungaristos, A, Katafigioti, D, Mitropoulos, C A, Constantinides
Publikováno v:
Minerva ginecologica. 67(3)
Our objectives were to evaluate the efficacy of the Perigee™ transoburator (TOT) mesh kit (American Medical Systems [AMS]-Minnetonka, MN, USA) in the treatment of ≥ stage 2 symptomatic AVP following a 2-year follow-up and to discuss the role of t